JP2007532135A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007532135A5 JP2007532135A5 JP2007508478A JP2007508478A JP2007532135A5 JP 2007532135 A5 JP2007532135 A5 JP 2007532135A5 JP 2007508478 A JP2007508478 A JP 2007508478A JP 2007508478 A JP2007508478 A JP 2007508478A JP 2007532135 A5 JP2007532135 A5 JP 2007532135A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- protein coupled
- agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *c1c(CC(N(CC2)CCC2c2nc(C(N(*)*)=O)c[s]2)=O)cccc1 Chemical compound *c1c(CC(N(CC2)CCC2c2nc(C(N(*)*)=O)c[s]2)=O)cccc1 0.000 description 1
- ZLJDFWOXKCVPNS-UHFFFAOYSA-N O=C(Cc1ccccc1Cl)N(CC1)CCC1c1nc(C(N(CCC2)c3c2cccc3)=O)c[s]1 Chemical compound O=C(Cc1ccccc1Cl)N(CC1)CCC1c1nc(C(N(CCC2)c3c2cccc3)=O)c[s]1 ZLJDFWOXKCVPNS-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56195404P | 2004-04-13 | 2004-04-13 | |
| PCT/US2005/012447 WO2005116653A2 (en) | 2004-04-13 | 2005-04-12 | Modulators of human g protein-coupled receptors for the treatment of hyperglycemia and related disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008104153A Division JP5769361B2 (ja) | 2004-04-13 | 2008-04-11 | 高血糖症および関連障害の処置のための、ヒトｇタンパク質共役レセプターおよびそのモジュレーター |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007532135A JP2007532135A (ja) | 2007-11-15 |
| JP2007532135A5 true JP2007532135A5 (enExample) | 2008-05-29 |
Family
ID=35451510
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007508478A Pending JP2007532135A (ja) | 2004-04-13 | 2005-04-12 | 高血糖症および関連障害の処置のための、ヒトｇタンパク質共役レセプターおよびそのモジュレーター |
| JP2008104153A Expired - Fee Related JP5769361B2 (ja) | 2004-04-13 | 2008-04-11 | 高血糖症および関連障害の処置のための、ヒトｇタンパク質共役レセプターおよびそのモジュレーター |
| JP2011226811A Pending JP2012050454A (ja) | 2004-04-13 | 2011-10-14 | 高血糖症および関連障害の処置のための、ヒトｇタンパク質共役レセプターおよびそのモジュレーター |
| JP2014209937A Pending JP2015064359A (ja) | 2004-04-13 | 2014-10-14 | 高血糖症および関連障害の処置のための、ヒトｇタンパク質共役レセプターおよびそのモジュレーター |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008104153A Expired - Fee Related JP5769361B2 (ja) | 2004-04-13 | 2008-04-11 | 高血糖症および関連障害の処置のための、ヒトｇタンパク質共役レセプターおよびそのモジュレーター |
| JP2011226811A Pending JP2012050454A (ja) | 2004-04-13 | 2011-10-14 | 高血糖症および関連障害の処置のための、ヒトｇタンパク質共役レセプターおよびそのモジュレーター |
| JP2014209937A Pending JP2015064359A (ja) | 2004-04-13 | 2014-10-14 | 高血糖症および関連障害の処置のための、ヒトｇタンパク質共役レセプターおよびそのモジュレーター |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20080306114A1 (enExample) |
| EP (1) | EP1735622A2 (enExample) |
| JP (4) | JP2007532135A (enExample) |
| CN (1) | CN101027560A (enExample) |
| AU (1) | AU2005248722A1 (enExample) |
| CA (1) | CA2564139A1 (enExample) |
| TW (1) | TW200539867A (enExample) |
| WO (1) | WO2005116653A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005023253A1 (en) | 2003-09-05 | 2005-03-17 | Altana Pharma Ag | Use of pde4 inhibitors for the treatment of diabetes mellitus |
| WO2006094942A1 (en) * | 2005-03-08 | 2006-09-14 | Nycomed Gmbh | Roflumilast for the treatment of diabetes mellitus |
| AU2006222060B2 (en) | 2005-03-08 | 2011-09-01 | Takeda Gmbh | Roflumilast for the treatment of diabetes mellitus |
| TW200738701A (en) * | 2005-07-26 | 2007-10-16 | Du Pont | Fungicidal carboxamides |
| WO2007100618A2 (en) * | 2006-02-23 | 2007-09-07 | Atto Bioscience | Novel cell-based phosphodiesterase assays |
| WO2007115805A2 (en) * | 2006-04-05 | 2007-10-18 | European Molecular Biology Laboratory (Embl) | Aurora kinase inhibitors |
| WO2008013622A2 (en) | 2006-07-27 | 2008-01-31 | E. I. Du Pont De Nemours And Company | Fungicidal azocyclic amides |
| US9090604B2 (en) | 2006-07-27 | 2015-07-28 | E I Du Pont De Nemours And Company | Fungicidal azocyclic amides |
| US7638541B2 (en) | 2006-12-28 | 2009-12-29 | Metabolex Inc. | 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
| BRPI0806214A2 (pt) | 2007-01-25 | 2011-08-30 | Du Pont | composto, método para o controla das doenças vegetais causadas por patogenos vegetais fúngicos oomycete e composições fungicidas |
| JP5489997B2 (ja) | 2007-07-19 | 2014-05-14 | シマベイ セラピューティクス， インコーポレーテッド | 糖尿病および代謝疾患の治療のためのＲＵＰ３またはＧＰＲｌ１９受容体のアゴニストとしてのＮ−アザ環状置換ピロール、ピラゾール、イミダゾール、トリアゾールおよびテトラゾール誘導体 |
| DE102007047735A1 (de) * | 2007-10-05 | 2009-04-09 | Merck Patent Gmbh | Thiazolderivate |
| TWI428091B (zh) | 2007-10-23 | 2014-03-01 | Du Pont | 殺真菌劑混合物 |
| WO2010117090A1 (en) * | 2009-04-10 | 2010-10-14 | Banyu Pharmaceutical Co.,Ltd. | Novel isoquinolinyloxymethyl heteroaryl derivatives |
| WO2010117084A1 (en) * | 2009-04-10 | 2010-10-14 | Banyu Pharmaceutical Co.,Ltd. | Novel isoquinoline derivatives |
| WO2011041154A1 (en) | 2009-10-01 | 2011-04-07 | Metabolex, Inc. | Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts |
| WO2011051244A1 (de) | 2009-10-30 | 2011-05-05 | Bayer Cropscience Ag | Heteroarylpiperidin und -piperazin derivate |
| CN111700901A (zh) * | 2010-01-08 | 2020-09-25 | Ionis制药公司 | 血管生成素样3表达的调节 |
| EP3493807A1 (en) | 2016-08-03 | 2019-06-12 | CymaBay Therapeutics, Inc. | Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions |
| CN113082020A (zh) * | 2021-04-08 | 2021-07-09 | 徐州医科大学 | 一种腺苷受体激动剂的增强剂及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5462856A (en) * | 1990-07-19 | 1995-10-31 | Bunsen Rush Laboratories, Inc. | Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins |
| US6060465A (en) * | 1997-02-06 | 2000-05-09 | Miljkovic; Dusan | Bile acids and their derivatives as glycoregulatory agents |
| JP2002000281A (ja) | 2000-04-12 | 2002-01-08 | Takeda Chem Ind Ltd | 新規ｇ蛋白質共役型レセプター蛋白質およびそのｄｎａ |
| JP4003069B2 (ja) * | 2000-11-17 | 2007-11-07 | 萬有製薬株式会社 | 新規なグアノシン三リン酸（ｇｔｐ）結合タンパク質共役型のレセプタータンパク質、ｂｇ３７ |
| JP4184697B2 (ja) * | 2001-04-12 | 2008-11-19 | 武田薬品工業株式会社 | スクリーニング方法 |
| WO2002084286A1 (en) * | 2001-04-12 | 2002-10-24 | Takeda Chemical Industries, Ltd. | Screening method |
| GB0230162D0 (en) * | 2002-12-24 | 2003-02-05 | Metris Therapeutics Ltd | Compounds useful in inhibiting angiogenesis |
| JP2004346059A (ja) * | 2003-01-28 | 2004-12-09 | Takeda Chem Ind Ltd | 受容体作動薬 |
| CA2514547A1 (en) * | 2003-01-28 | 2004-08-12 | Takeda Pharmaceutical Company Limited | Receptor agonists |
-
2005
- 2005-04-12 EP EP05780020A patent/EP1735622A2/en not_active Withdrawn
- 2005-04-12 US US11/578,257 patent/US20080306114A1/en not_active Abandoned
- 2005-04-12 JP JP2007508478A patent/JP2007532135A/ja active Pending
- 2005-04-12 AU AU2005248722A patent/AU2005248722A1/en not_active Withdrawn
- 2005-04-12 TW TW094111561A patent/TW200539867A/zh unknown
- 2005-04-12 CA CA002564139A patent/CA2564139A1/en not_active Abandoned
- 2005-04-12 CN CNA2005800187303A patent/CN101027560A/zh not_active Withdrawn
- 2005-04-12 WO PCT/US2005/012447 patent/WO2005116653A2/en not_active Ceased
-
2008
- 2008-04-11 JP JP2008104153A patent/JP5769361B2/ja not_active Expired - Fee Related
-
2011
- 2011-10-14 JP JP2011226811A patent/JP2012050454A/ja active Pending
-
2014
- 2014-10-14 JP JP2014209937A patent/JP2015064359A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Smith | Development of growth hormone secretagogues | |
| Kukkonen et al. | Functions of the orexinergic/hypocretinergic system | |
| CA2593427A1 (en) | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level | |
| Olarescu et al. | Normal physiology of growth hormone in adults | |
| TW200946911A (en) | Methods of using a g protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY | |
| RU2423378C2 (ru) | Композиции и способы, связанные с растворимыми сопряженными с g-белком рецепторами (sgpcr) | |
| Turnbull et al. | Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats | |
| TW200809200A (en) | Methods of using GPR119 receptor to identify compounds useful for increasing bone mass in an individual | |
| EA013121B1 (ru) | Амилин и агонисты амилина для лечения психиатрических заболеваний и расстройств | |
| Costantini et al. | GSK1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogs | |
| US20080182811A1 (en) | Metabotropic glutamate receptor activator | |
| Baraboi et al. | Lesions of area postrema and subfornical organ alter exendin-4-induced brain activation without preventing the hypophagic effect of the GLP-1 receptor agonist | |
| JP2011516486A (ja) | 骨質量疾患の診断、予防、及び治療方法 | |
| Jung et al. | Electrophysiological, behavioural and biochemical evidence for activation of brain noradrenergic systems following neurokinin receptor stimulation | |
| KR20080034877A (ko) | 비만 치료를 위한 약리학적 샤폐론 | |
| Bond et al. | Increased maternofetal calcium flux in parathyroid hormone‐related protein‐null mice | |
| Ding et al. | Glucose-dependent insulinotropic peptide stimulates thymidine incorporation in endothelial cells: role of endothelin-1 | |
| JP2008501632A5 (enExample) | ||
| JP2019501925A (ja) | Ｇｄｆ１１での処置は、体重増加を防止し、耐糖能を改善し、そして脂肪肝を低減する | |
| EP2002827A2 (en) | Methods and compositions for control of bone formation via modulation of sympathetic tone | |
| TWI291555B (en) | Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure | |
| JP2003512040A (ja) | 変異α２Ｂ−アドレノセプター・タンパク質をコードするＤＮＡ分子及びその使用 | |
| Parkinson et al. | The place of pegvisomant in the management of acromegaly | |
| JP2005534319A5 (enExample) | ||
| Przydzial et al. | Nociceptin/orphanin FQ peptide receptor as a therapeutic target for obesity |